Test Bank - Essentials of Pharmacology for Health Professions, 9th Edition - Colbert
1 and Katrancha 2026/03/09
Page 1 of 742 Test Bank - Essentials of
Page
Pharmacology
1 for Health Professions, 9th Edition - Colbert and Katrancha.docx
,Test Bank - Essentials of Pharmacology for Health Professions, 9th Edition - Colbert
2 and Katrancha 2026/03/09
1. A client calls her primary care provider requesting a prescription for an antidepressant medication. She tells
the nurse that she is severely depressed and would like the prescription called in to her local pharmacy. How
should the nurse respond?
a. The nurse encourages the client to see a psychiatric professional for an evaluation to obtain the
prescription.
b. The nurse tells the client to ask the pharmacist to recommend an over-the-counter antidepressant.
c. The nurse can offer to write the client a prescription if it is a refill.
d. The nurse offers to give the client a few samples to use until her next appointment.
ANSWER: a
FEEDBACK: a. The client should be encouraged to seek a psychiatric professional evaluation to obtain
the prescription.
b. Antidepressants are not sold as over-the-counter medications; a prescription is required.
Try again.
c. The nurse cannot write a prescription without evaluating the client. Try again.
d. Samples are not given out to a client who has not been evaluated by a practitioner. Try
again.
POINTS: 1
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
DATE CREATED: 11/26/2017 8:16 PM
DATE MODIFIED: 11/26/2017 8:32 PM
2. A client visits her health care provider for her annual physical. She questions the nurse regarding the use of
an herbal supplement that she saw advertised on television for weight loss. What information can the nurse
share with her client?
a. The production of herbal medicines is not regulated by the FDA.
b. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA is responsible
for ensuring that a dietary supplement is safe before it is marketed.
c. Herbal medicines are tested by the FDA to determine if they have interactions with prescribed
medications.
d. Herbal medicines, while not approved by the FDA, are considered harmless.
ANSWER: a
FEEDBACK: a. The production of herbal medicines is not regulated by the FDA.
b. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the dietary
manufacturer is responsible for ensuring that a dietary supplement is safe before it is
marketed. Try again.
c. The FDA does not test supplements. Try again.
d. There are documented interactions with specific herbal supplements and prescribed
medications. Try again.
POINTS:
1
Page 2 of 742 Test Bank - Essentials of
Page
Pharmacology
2 for Health Professions, 9th Edition - Colbert and Katrancha.docx
,Test Bank - Essentials of Pharmacology for Health Professions, 9th Edition - Colbert
3 and Katrancha 2026/03/09
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
DATE CREATED: 11/26/2017 8:22 PM
DATE MODIFIED: 11/26/2017 8:32 PM
3. Upon leaving the exam room, a client tells the nurse that she is confused regarding her prescription. She asks
the nurse if a cheaper, generic drug will be weaker than her current prescription. How should the nurse respond?
a. Drug standards assure consumers that the same drug must be of uniform strength, quality, and purity.
b. The prescribed medication is of better quality but will cost more.
c. The insurance companies mandate there are different strengths between generic and brand name
prescriptions.
d. Every drug has a different chemical composition that cannot be duplicated.
ANSWER: a
FEEDBACK: a. Drug standards assure consumers that the same drug must be of uniform strength,
quality, and purity.
b. Generic and trade drugs are the same medication. Generic is the name that is assigned
to a new drug. The trade name is the name the pharmaceutical company assigns to that
drug to have exclusive rights to market it. Try again.
c. Insurance companies have no control over the production of medication. Try again.
d. The laws regulating drugs state that consumers can be assured that all preparations
with the same name have the same uniform strength, quality, and purity. Try again.
POINTS: 1
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
DATE CREATED: 11/26/2017 8:23 PM
DATE MODIFIED: 11/26/2017 8:31 PM
4. The FDA, under the direction of the Department of Health and Human Services, mandates which of the
following?
a. Prescription and nonprescription drugs must be shown to be effective as well as safe.
b. All labels must include a listing of active ingredients; some labels require a listing of inactive
ingredients as well.
c. All new products must be tested by the FDA before being released to the public.
d. All drugs must have "warning" labels.
ANSWER: a
FEEDBACK: a. Prescription and nonprescription drugs must be shown to be effective as well as safe.
b. All labels must be accurate and must include a listing of all active and inactive
ingredients. Try again.
c. The FDA must approve all new products before they are released to the public. Try
again.
d. Warning labels must be present on certain preparations. Try again.
POINTS: 1
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
Page 3 of 742 Test Bank - Essentials of
Page
Pharmacology
3 for Health Professions, 9th Edition - Colbert and Katrancha.docx
, Test Bank - Essentials of Pharmacology for Health Professions, 9th Edition - Colbert
4 and Katrancha 2026/03/09
DATE CREATED: 11/26/2017 8:26 PM
DATE MODIFIED: 11/26/2017 8:30 PM
5. An older adult client is reluctant to take any prescribed medications and questions the nurse about the
production process and safety of her medications. How should the nurse respond?
a. Federal laws require all drugs marketed in the United States to meet the minimal standards of
strength, purity, and quality.
b. Most medications are made outside the United States.
c. Pharmaceutical companies follow their own guidelines.
d. Insurance carriers set the parameters for drug manufacturing.
ANSWER: a
FEEDBACK: a. Federal laws require all drugs marketed in the United States to meet the minimal
standards of strength, purity, and quality.
b. Medications made out of the United States or illegally are not controlled by drug
standards. Try again.
c. Although pharmaceutical companies do have guidelines, the final authorization for
released products is through the FDA. Try again.
d. Insurance carriers do not manufacture medications. Try again.
POINTS: 1
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
DATE CREATED: 11/26/2017 8:33 PM
DATE MODIFIED: 11/26/2017 8:35 PM
6. The nurse in the local drug prevention clinic is asked by a client about the relative danger of various drugs.
She explains that the Drug Enforcement Administration (DEA) classifies drugs that can be abused or have
addictive properties into categories or schedules. Which of the following are factors that are considered when
classifying the schedule of a particular drug? (SELECT ALL THAT APPLY.)
a. the potential cost to produce the drug
b. the medical value of the drug
c. the harmfulness of the drug
d. the potential for abuse or addiction
e. the popularity of the medication
ANSWER: b, c, d
FEEDBACK: a. The cost to produce a drug is not a category classified by the DEA.
b. The Drug Enforcement Administration divides controlled substances into five levels or
schedules according to their medical value.
c. Harmfulness of a drug is one criterion that the DEA uses to categorize a drug.
d. Potential for abuse is one criterion that the DEA uses to categorize drugs.
e. The popularity of the medication is not considered. The DEA does take into
consideration societal problems with medication and that may cause the medication to
be moved from one schedule to another.
POINTS: 1
QUESTION TYPE: Multiple Response
Page 4 of 742 Test Bank - Essentials of
Page
Pharmacology
4 for Health Professions, 9th Edition - Colbert and Katrancha.docx
1 and Katrancha 2026/03/09
Page 1 of 742 Test Bank - Essentials of
Page
Pharmacology
1 for Health Professions, 9th Edition - Colbert and Katrancha.docx
,Test Bank - Essentials of Pharmacology for Health Professions, 9th Edition - Colbert
2 and Katrancha 2026/03/09
1. A client calls her primary care provider requesting a prescription for an antidepressant medication. She tells
the nurse that she is severely depressed and would like the prescription called in to her local pharmacy. How
should the nurse respond?
a. The nurse encourages the client to see a psychiatric professional for an evaluation to obtain the
prescription.
b. The nurse tells the client to ask the pharmacist to recommend an over-the-counter antidepressant.
c. The nurse can offer to write the client a prescription if it is a refill.
d. The nurse offers to give the client a few samples to use until her next appointment.
ANSWER: a
FEEDBACK: a. The client should be encouraged to seek a psychiatric professional evaluation to obtain
the prescription.
b. Antidepressants are not sold as over-the-counter medications; a prescription is required.
Try again.
c. The nurse cannot write a prescription without evaluating the client. Try again.
d. Samples are not given out to a client who has not been evaluated by a practitioner. Try
again.
POINTS: 1
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
DATE CREATED: 11/26/2017 8:16 PM
DATE MODIFIED: 11/26/2017 8:32 PM
2. A client visits her health care provider for her annual physical. She questions the nurse regarding the use of
an herbal supplement that she saw advertised on television for weight loss. What information can the nurse
share with her client?
a. The production of herbal medicines is not regulated by the FDA.
b. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA is responsible
for ensuring that a dietary supplement is safe before it is marketed.
c. Herbal medicines are tested by the FDA to determine if they have interactions with prescribed
medications.
d. Herbal medicines, while not approved by the FDA, are considered harmless.
ANSWER: a
FEEDBACK: a. The production of herbal medicines is not regulated by the FDA.
b. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the dietary
manufacturer is responsible for ensuring that a dietary supplement is safe before it is
marketed. Try again.
c. The FDA does not test supplements. Try again.
d. There are documented interactions with specific herbal supplements and prescribed
medications. Try again.
POINTS:
1
Page 2 of 742 Test Bank - Essentials of
Page
Pharmacology
2 for Health Professions, 9th Edition - Colbert and Katrancha.docx
,Test Bank - Essentials of Pharmacology for Health Professions, 9th Edition - Colbert
3 and Katrancha 2026/03/09
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
DATE CREATED: 11/26/2017 8:22 PM
DATE MODIFIED: 11/26/2017 8:32 PM
3. Upon leaving the exam room, a client tells the nurse that she is confused regarding her prescription. She asks
the nurse if a cheaper, generic drug will be weaker than her current prescription. How should the nurse respond?
a. Drug standards assure consumers that the same drug must be of uniform strength, quality, and purity.
b. The prescribed medication is of better quality but will cost more.
c. The insurance companies mandate there are different strengths between generic and brand name
prescriptions.
d. Every drug has a different chemical composition that cannot be duplicated.
ANSWER: a
FEEDBACK: a. Drug standards assure consumers that the same drug must be of uniform strength,
quality, and purity.
b. Generic and trade drugs are the same medication. Generic is the name that is assigned
to a new drug. The trade name is the name the pharmaceutical company assigns to that
drug to have exclusive rights to market it. Try again.
c. Insurance companies have no control over the production of medication. Try again.
d. The laws regulating drugs state that consumers can be assured that all preparations
with the same name have the same uniform strength, quality, and purity. Try again.
POINTS: 1
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
DATE CREATED: 11/26/2017 8:23 PM
DATE MODIFIED: 11/26/2017 8:31 PM
4. The FDA, under the direction of the Department of Health and Human Services, mandates which of the
following?
a. Prescription and nonprescription drugs must be shown to be effective as well as safe.
b. All labels must include a listing of active ingredients; some labels require a listing of inactive
ingredients as well.
c. All new products must be tested by the FDA before being released to the public.
d. All drugs must have "warning" labels.
ANSWER: a
FEEDBACK: a. Prescription and nonprescription drugs must be shown to be effective as well as safe.
b. All labels must be accurate and must include a listing of all active and inactive
ingredients. Try again.
c. The FDA must approve all new products before they are released to the public. Try
again.
d. Warning labels must be present on certain preparations. Try again.
POINTS: 1
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
Page 3 of 742 Test Bank - Essentials of
Page
Pharmacology
3 for Health Professions, 9th Edition - Colbert and Katrancha.docx
, Test Bank - Essentials of Pharmacology for Health Professions, 9th Edition - Colbert
4 and Katrancha 2026/03/09
DATE CREATED: 11/26/2017 8:26 PM
DATE MODIFIED: 11/26/2017 8:30 PM
5. An older adult client is reluctant to take any prescribed medications and questions the nurse about the
production process and safety of her medications. How should the nurse respond?
a. Federal laws require all drugs marketed in the United States to meet the minimal standards of
strength, purity, and quality.
b. Most medications are made outside the United States.
c. Pharmaceutical companies follow their own guidelines.
d. Insurance carriers set the parameters for drug manufacturing.
ANSWER: a
FEEDBACK: a. Federal laws require all drugs marketed in the United States to meet the minimal
standards of strength, purity, and quality.
b. Medications made out of the United States or illegally are not controlled by drug
standards. Try again.
c. Although pharmaceutical companies do have guidelines, the final authorization for
released products is through the FDA. Try again.
d. Insurance carriers do not manufacture medications. Try again.
POINTS: 1
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
DATE CREATED: 11/26/2017 8:33 PM
DATE MODIFIED: 11/26/2017 8:35 PM
6. The nurse in the local drug prevention clinic is asked by a client about the relative danger of various drugs.
She explains that the Drug Enforcement Administration (DEA) classifies drugs that can be abused or have
addictive properties into categories or schedules. Which of the following are factors that are considered when
classifying the schedule of a particular drug? (SELECT ALL THAT APPLY.)
a. the potential cost to produce the drug
b. the medical value of the drug
c. the harmfulness of the drug
d. the potential for abuse or addiction
e. the popularity of the medication
ANSWER: b, c, d
FEEDBACK: a. The cost to produce a drug is not a category classified by the DEA.
b. The Drug Enforcement Administration divides controlled substances into five levels or
schedules according to their medical value.
c. Harmfulness of a drug is one criterion that the DEA uses to categorize a drug.
d. Potential for abuse is one criterion that the DEA uses to categorize drugs.
e. The popularity of the medication is not considered. The DEA does take into
consideration societal problems with medication and that may cause the medication to
be moved from one schedule to another.
POINTS: 1
QUESTION TYPE: Multiple Response
Page 4 of 742 Test Bank - Essentials of
Page
Pharmacology
4 for Health Professions, 9th Edition - Colbert and Katrancha.docx
